Why is tirzepatide dosed in units instead of milligrams?
Compounded tirzepatide is typically supplied as a multi-dose vial in liquid form. To draw the correct dose, patients use an insulin syringe — the same type used for insulin therapy. Insulin syringes measure volume in units, where 100 units equals 1 mL of fluid.
This means “units” in the context of tirzepatide dosing describes a volume measurement on a syringe, not a biologically active unit of the peptide itself. The medication’s actual potency is determined by the concentration of tirzepatide dissolved in that volume — the mg/mL figure on your pharmacy label.
The formula is simple:
mg = (units ÷ 100) × concentration (mg/mL)
Example: 50 units at 5 mg/mL = (50 ÷ 100) × 5 = 2.5 mg
Conversion table: common tirzepatide concentrations
The table below shows the milligram equivalent for common syringe volumes across several concentrations used in compounded tirzepatide preparations. Your vial label will state the exact concentration — always use that figure, not an assumed value.
| Concentration | 10 units | 20 units | 50 units | 100 units (1 mL) |
|---|---|---|---|---|
| 2.5 mg/mL | 0.25 mg | 0.5 mg | 1.25 mg | 2.5 mg |
| 5 mg/mL | 0.5 mg | 1 mg | 2.5 mg | 5 mg |
| 10 mg/mL | 1 mg | 2 mg | 5 mg | 10 mg |
| 12.5 mg/mL | 1.25 mg | 2.5 mg | 6.25 mg | 12.5 mg |
| 20 mg/mL | 2 mg | 4 mg | 10 mg | 20 mg |
The 50-unit column is highlighted because it is the most common search query. At 5 mg/mL — a frequently used compounded concentration — 50 units equals 2.5 mg, which corresponds to the standard tirzepatide starting dose.
A “unit” measures volume on the syringe, not potency — the concentration on your label is what turns those units into milligrams.
Standard tirzepatide dosing schedule
For context on where your prescribed dose falls in the typical protocol:
- Weeks 1–4: 2.5 mg once weekly (tolerability step, not therapeutic dose)
- Weeks 5–8: 5 mg once weekly
- Weeks 9–12: 7.5 mg once weekly (if tolerated)
- Weeks 13–16: 10 mg once weekly (if tolerated)
- Weeks 17–20: 12.5 mg once weekly (if tolerated)
- Week 21+: 15 mg once weekly (maximum studied dose, if tolerated and clinically appropriate)
Your clinician may prescribe a different titration schedule based on your response, tolerance, and clinical picture. The schedule above reflects the SURMOUNT trial protocol; individual variation is common and expected.
Why does concentration accuracy matter for tirzepatide dosing?
Unlike medication in pre-filled pens, compounded tirzepatide requires the patient to draw the correct volume from a multi-dose vial. Two vials that look identical but have different concentrations will produce different doses at the same syringe marking. This is why:
- Always read the pharmacy label before drawing each dose. Concentrations can differ between refills, between pharmacies, or if your clinician adjusts your protocol.
- If your label does not state the concentration clearly, contact your pharmacy before injecting.A label that states only “Tirzepatide” without a mg/mL figure is incomplete.
- Never convert a dose you looked up online if it differs from what your clinician prescribed. Dosing should only be adjusted in consultation with your prescriber.
Compounded tirzepatide and 503A pharmacies
Compounded tirzepatide is prepared by licensed 503A compounding pharmacies in the USA using pharmaceutical-grade active pharmaceutical ingredients. A 503A pharmacy compounds medications for individual patients on a clinician’s prescription, with quality standards governed by USP regulations.
Patients who obtain tirzepatide from unregulated sources — overseas suppliers, research chemical vendors, or gray-market channels — have no reliable way to verify the concentration, purity, or sterility of what they are injecting. The conversion math in this article assumes you have a labeled product from a licensed pharmacy. If you do not, the first step is to transition to a clinician-supervised program before attempting any dose calculation.
Frequently asked questions
How many mg is 50 units of tirzepatide?
It depends on your vial concentration. At 5 mg/mL (a common compounded concentration), 50 units on an insulin syringe (which measures 0.5 mL) equals 2.5 mg. At 10 mg/mL, 50 units equals 5 mg. Always verify the concentration on your pharmacy label and use only the volume your clinician prescribed.
How do I convert tirzepatide units to mg?
Multiply the volume in mL by the concentration in mg/mL. 100 units on an insulin syringe = 1 mL. So 50 units = 0.5 mL. At 5 mg/mL that is 2.5 mg; at 10 mg/mL that is 5 mg. Your pharmacy label should state the concentration explicitly.
What is a standard starting dose of tirzepatide?
The standard starting dose for tirzepatide weight management is 2.5 mg weekly for the first 4 weeks, titrating upward as tolerated. The maximum studied dose is 15 mg weekly. Compounded tirzepatide concentrations vary; your clinician will prescribe the volume to inject based on your vial's specific concentration.
Why is my tirzepatide dosed in units instead of mg?
Compounded peptides are often drawn with insulin syringes, which measure in units (100 units = 1 mL). Expressing the prescribed dose as a volume in units makes it easier to measure accurately with a standard insulin syringe. Your pharmacist and clinician calculate the correct unit volume based on your vial concentration.
Can I change my tirzepatide dose without talking to my clinician?
No. Dose adjustments for tirzepatide should only be made in consultation with your prescribing clinician. Increasing the dose too quickly is one of the primary causes of GI side effects. Decreasing without clinical guidance may reduce effectiveness.